RxDoctor Payments Data
★ My doctorsLook up a doctor →

Bhupinder Mangat

Sanford, FLNPI 1043213234

Payments from drug & device makers

$5,069in general payments, 2019–2025

Across 289 payments — averaging $17.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$767
  • Biogen$646
  • Biohaven Pharmaceuticals, Inc.$377
  • Sanofi$361
  • Lilly USA, LLC$253
  • Amgen$252
  • plus $2K from 25 others

What the payments were for

  • Food & beverage$5,069100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)65$767
Biogen35$646
Biohaven Pharmaceuticals, Inc.21$377
Sanofi19$361
Lilly USA, LLC12$253
Amgen(2 entities)12$252
Teva Pharmaceuticals USA, Inc.12$249
Tanabe Pharma America, Inc.10$221
Novartis12$207
Biohaven Pharmaceutical Holding Company Ltd.9$186
Mallinckrodt Hospital Products Inc.9$169
UCB, Inc.7$160
EMD Serono, Inc.9$148
Acadia Pharmaceuticals Inc7$143
Johnson & Johnson6$133
Adamas Pharmaceuticals, Inc.8$127
Supernus Pharmaceuticals, Inc.7$91
Genentech USA, Inc.5$82
Lundbeck LLC1$73
Alnylam Pharmaceuticals Inc.3$72
E.r. Squibb & Sons, L.L.C.3$68
Bausch Health US, LLC4$50
Vertical Pharmaceuticals, LLC2$41
Assertio Therapeutics, Inc.2$33
AstraZeneca2$33
Catalyst Pharmaceuticals, Inc.1$32
Amneal Pharmaceuticals LLC2$29
Mallinckrodt Enterprises LLC1$20
Neurocrine Biosciences, Inc.1$18
Upsher-smith Laboratories LLC1$15
Bristol Myers Squibb1$12

Where these figures come from

Is this you, or does something look wrong? →